(Q40096020)

17 September 2017

title

Cardiometabolic disease in human immunodeficiency virus-infected children (English)

1 reference

17 September 2017

5

Steven E Lipshultz

1 reference

17 September 2017

Tracie L Miller

1

1 reference

17 September 2017

Yoran T Grant

series ordinal

2

1 reference

17 September 2017

Daniela Neri Almeida

series ordinal

3

1 reference

17 September 2017

Tanvi Sharma

series ordinal

4

1 reference

17 September 2017

publication date

1 January 2008

1 reference

Journal of the cardiometabolic syndrome

17 September 2017

published in

1 reference

17 September 2017

volume

3

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

98-105

1 reference

International perspectives, progress, and future challenges of paediatric HIV infection

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Activation of the signal transducer and activator of transcription 1 signaling pathway in thymocytes from HIV-1-infected human thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Metabolic complications of HIV therapy in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+ -lymphocyte count and CD4+ -lymphocyte percentage at baseline and use of protease inhibitors and stavudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Prevalence of lipodystrophy in HIV-infected children: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Lipodystrophy syndrome in human immunodeficiency virus-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Long-term responses to treatment including ritonavir or nelfinavir in HIV-1-infected children. Pediatric AIDS Group of Switzerland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Hyperlipidemia in HIV-infected children treated with protease inhibitors: relevance for cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Dyslipidemia among perinatally HIV-infected children enrolled in the PACTS-HOPE cohort, 1999-2004: a longitudinal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

The metabolic effects of lopinavir/ritonavir in HIV-negative men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Atherosclerosis in AIDS: potential pathogenetic roles of antiretroviral therapy and HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

The mechanism of insulin resistance caused by HIV protease inhibitor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Insulin sensitivity and beta-cell function in protease inhibitor-treated and -naive human immunodeficiency virus-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Cardiovascular manifestations of human immunodeficiency virus infection in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Alterations in cardiac and pulmonary function in pediatric rapid human immunodeficiency virus type 1 disease progressors. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Cardiac structure and function in fetuses of mothers infected with HIV: the prospective PCHIV multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study. P2C2 HIV Study Group, National Heart, Lung, and Blood Institute, Bethesda, Maryland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

HIV, metabolic syndrome X, inflammation, oxidative stress, and coronary heart disease risk : role of protease inhibitor exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Primary Prevention of Cardiovascular Disease in Nursing Practice: Focus on Children and Youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

Apoprotein C-III and E-Containing Lipoparticles Are Markedly Increased in HIV-Infected Patients Treated with Protease Inhibitors: Association with the Development of Lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4572.2008.07651.X

10.1111/J.1559-4572.2008.07651.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference